IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
- PMID:11544464
- DOI:10.1067/mai.2001.117929
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Abstract
Background:IL-17 is a cytokine that has been reported to be produced by T lymphocytes. In vitro, IL-17 activates fibro-blasts and macrophages for the secretion of GM-CSF, TNF-alpha, IL-1beta, and IL-6. A number of these cytokines are involved in the airway remodeling that is observed within the lungs of asthmatic individuals.
Objective:In this study, we investigated the expression of IL-17 in sputum and bronchoalveolar lavage specimens obtained from asthmatic subjects and from nonasthmatic control subjects.
Methods:通过使用immunocytochemis IL-17检测try, in situ hybridization, and Western blot. Bronchial fibroblasts were stimulated with IL-17, and cytokine production and chemokine production were detected through use of ELISA and RT-PCR.
Results:Using immunocytochemistry, we demonstrated that the numbers of cells positive for IL-17 are significantly increased in sputum and bronchoalveolar lavage fluids of subjects with asthma in comparison with control subjects (P <.001 and P <.005, respectively). We demonstrated that in addition to T cells, eosinophils in sputum and bronchoalveolar lavage fluids expressed IL-17. Peripheral blood eosinophils were also positive for IL-17, and the level of IL-17 in eosinophils purified from peripheral blood was significantly higher in subjects with asthma than in controls (P <.01). To further investigate the mechanism of action of IL-17 in vivo, we examined the effect of this cytokine on fibroblasts isolated from bronchial biopsies of asthmatic and nonasthmatic subjects. IL-17 did enhance the production of pro-fibrotic cytokines (IL-6 and IL-11) by fibroblasts, and this was inhibited by dexamethasone. Similarly, IL-17 increased the level of other fibroblast-derived inflammatory mediators, such as the alpha-chemokines, IL-8, and growth-related oncogene-alpha.
Conclusion:Our results, which demonstrate for the first time that eosinophils are a potential source of IL-17 within asthmatic airways, suggest that IL-17 might have the potential to amplify inflammatory responses through the release of proinflammatory mediators such as alpha-chemokines.
Similar articles
-
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.J Allergy Clin Immunol. 2006 Mar;117(3):590-6. doi: 10.1016/j.jaci.2005.10.025. Epub 2006 Feb 8. J Allergy Clin Immunol. 2006. PMID:16522458
-
IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma.J Immunol. 1995 May 15;154(10):5481-90. J Immunol. 1995. PMID:7730650
-
Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma.J Allergy Clin Immunol. 2000 Aug;106(2):293-301. doi: 10.1067/mai.2000.108112. J Allergy Clin Immunol. 2000. PMID:10932073
-
Cytokines in chronic obstructive pulmonary disease.Eur Respir J Suppl. 2001 Dec;34:50s-59s. Eur Respir J Suppl. 2001. PMID:12392035 Review.
-
[Cell biology of bronchial asthma: interesting new methods. Intracellular determination of cytokines in T-cells and basic proteins in eosinophilic granulocytes using flow cytometry].Pneumologie. 1997 Apr;51(4):381-5. Pneumologie. 1997. PMID:9221385 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical